298 related articles for article (PubMed ID: 9922964)
61. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
62. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
[TBL] [Abstract][Full Text] [Related]
63. Mortality due to vancomycin-resistant enterococcal bacteremia versus vancomycin-susceptible enterococcal bacteremia: an ecological analysis.
Hurley JC
Clin Infect Dis; 2005 Nov; 41(10):1541-2. PubMed ID: 16231272
[No Abstract] [Full Text] [Related]
64. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
Werner G; Klare I; Spencker FB; Witte W
J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253
[TBL] [Abstract][Full Text] [Related]
65. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
Butt T; Afzal RK; Ahmad RN; Salman M; Mahmood A; Anwar M
J Ayub Med Coll Abbottabad; 2004; 16(1):18-22. PubMed ID: 15125174
[TBL] [Abstract][Full Text] [Related]
66. [Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l].
Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
Rev Esp Quimioter; 2008 Jun; 21(2):93-8. PubMed ID: 18509768
[TBL] [Abstract][Full Text] [Related]
67. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.
Edmond MB; Ober JF; Weinbaum DL; Pfaller MA; Hwang T; Sanford MD; Wenzel RP
Clin Infect Dis; 1995 May; 20(5):1126-33. PubMed ID: 7619987
[TBL] [Abstract][Full Text] [Related]
68. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
[TBL] [Abstract][Full Text] [Related]
69. Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.
Bae KS; Shin JA; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
Infection; 2019 Jun; 47(3):417-424. PubMed ID: 30565009
[TBL] [Abstract][Full Text] [Related]
70. Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization.
Noskin GA; Cooper I; Peterson LR
Arch Intern Med; 1995 Jul; 155(13):1445-7. PubMed ID: 7794095
[TBL] [Abstract][Full Text] [Related]
71. Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: clinical and molecular epidemiology.
Raad II; Hanna HA; Boktour M; Jabbour N; Hachem RY; Darouiche RO
Infect Control Hosp Epidemiol; 2005 Jul; 26(7):658-61. PubMed ID: 16092749
[TBL] [Abstract][Full Text] [Related]
72. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.
Mainous MR; Lipsett PA; O'Brien M
Arch Surg; 1997 Jan; 132(1):76-81. PubMed ID: 9006556
[TBL] [Abstract][Full Text] [Related]
73. [Analysis of 117 episodes of enterococcal bacteremia: Study of epidemiology, microbiology and antimicrobial susceptibility].
Manassero NC; Navarro M; Rocchi M; di Bella H; Gasparotto AM; Ocaña Carrizo AV; Novillo F; Furiasse D; Monterisi A
Rev Argent Microbiol; 2016; 48(4):298-302. PubMed ID: 27567523
[TBL] [Abstract][Full Text] [Related]
74. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.
Linden PK; Pasculle AW; Manez R; Kramer DJ; Fung JJ; Pinna AD; Kusne S
Clin Infect Dis; 1996 Apr; 22(4):663-70. PubMed ID: 8729206
[TBL] [Abstract][Full Text] [Related]
75. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
[TBL] [Abstract][Full Text] [Related]
76. Vancomycin-resistant enterococci.
Murray BE
Am J Med; 1997 Mar; 102(3):284-93. PubMed ID: 9217598
[TBL] [Abstract][Full Text] [Related]
77. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years.
Roghmann MC; Qaiyumi S; Johnson JA; Schwalbe R; Morris JG
Clin Infect Dis; 1997 Mar; 24(3):514-5. PubMed ID: 9114211
[No Abstract] [Full Text] [Related]
78. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.
Vergis EN; Hayden MK; Chow JW; Snydman DR; Zervos MJ; Linden PK; Wagener MM; Schmitt B; Muder RR
Ann Intern Med; 2001 Oct; 135(7):484-92. PubMed ID: 11578151
[TBL] [Abstract][Full Text] [Related]
79. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium.
Mekonen ET; Noskin GA; Hacek DM; Peterson LR
Microb Drug Resist; 1995; 1(3):249-53. PubMed ID: 9158783
[TBL] [Abstract][Full Text] [Related]
80. [Vancomycin-resistant enterococci in pediatric hematology: don't panic!].
Barbé G; Ploton C; Pondarré C; Bertrand Y; Souillet G; Philippe N
Pathol Biol (Paris); 1998 Jun; 46(6):408-11. PubMed ID: 9769870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
